China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. logo

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Ticker000999.SZVenueSHZSectorHealthcarePrimary listingBeta0.09
CN¥26.26+2.70%
FinScore68

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a China-based company in the Healthcare sector with a market capitalisation of $6.4B. Its FinScore is 68/100; its highest-scoring layer is Quality (74) and its lowest is Growth (51). The shares trade at 13.5x trailing earnings and are down 11% year to date.

Market cap
$6.4B
P/E (TTM)
13.5x
Dividend yield (TTM)
3.93%
ROE
11.8%

Share price performance

Loading chart…

About China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

www.999.com.cn

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.

Profile
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
HQ
China
Fiscal year-end
December
Trading currency
CNY
Reporting currency
CNY
Fundamentals updated
64 days ago
Market
Market cap
$6.4B
Shares outstanding
1.7B
P/E (TTM)
13.5x
Dividend yield (TTM)
3.93%
Beta (issuer)
0.09
Revenue (latest FY)
CN¥31.6B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall68
Quality74
Growth51
Value68
Momentum66
Relative Strength96

Snapshot

Ownership

Free float
36.7%
Shares outstanding
1.7B

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is available to Finryse members. The Overview stays open to everyone; creating an account is free.